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Summary 
The cytokine, interleukin 12 (IL-12), stimulates both natural killer cells and T cells to proliferate 
and to secrete interferon 3, (IFN-3~). The T cell proliferative response to IL-12 must be induced 
and is evident after T  cell receptor-mediated stimulation. As reported here,  tolerant CD4 § T 
cells and clones, that are anergic for IL-2 production, are also anergic for induction of the proliferative 
response to IL-12. Murine T helper I clones tolerized in vitro, as well as anergic CD4 + T cells 
isolated from mice tolerized to the Mls-P antigen (Ag) in vivo, demonstrated defective induction 
of proliferation to IL-12 upon restimulation with Ag. IL-12-enhanced production of IFN-'y was 
observed in both control and anergic cells after Ag/antigen-presenting cell (APC) activation, 
although total IFN-y secretion by anergic cells was less than that produced by control cells, 
even in the presence of IL-12.  These data indicate that T cell clonal anergy results in profound 
inhibition of proliferative  responses,  since the autocrine growth factor,  IL-2, is not produced, 
and the APC-derived cytokine, IL-12, is not an effective stimulus for anergic T cell proliferation. 
T  cell anergy can be induced in Thl clones  in vitro by 
ligation of the TCR in the absence  of costimulatory 
signals  (1-3),  and can also  be induced in vivo in mature 
CD4 + T cells by the injection of superantigens (4-6). Such 
anergy is characterized by a block in IL-2 production, resulting 
in proliferative nonresponsiveness  to Ag (7).  In addition, 
anergic Thl and Th0 clones are nonresponsive for the induc- 
tion of proliferation to IL-4 (8, 9). These data suggest that 
the focus of functional anergy is to prevent expansion of 
tolerant Ag-reactive clones upon Ag challenge. It was recently 
determined that the cytokine, IL-12, produced by macrophages 
and B ceils (10), stimulates the proliferation of T cells after 
TCR-induced activation and induces the production of IFN-3~ 
(11-13).  Furthermore,  IL-12  plays  an  important  role  in 
directing a predominantly Thl-like response in T cell popu- 
lations (14, 15). The work reported here demonstrates that 
anergic T cells are impaired for induction of proliferation to 
IL-12, as they are for induction of proliferation to IL-4 (8, 
9)  and for induction of IL-2 synthesis (1-3,  7). 
Materials and Methods 
Mice.  Female  B10.BR/SgSnJ or B10.A/SgSnJ mice were pur- 
chased from The Jackson Laboratory (Bar Harbor, ME) and were 
used at 6-12 wk of age as the source of splenocyte APC for the 
maintenance and stimulation ofT cell clones. Female  CBA/J (Mls- 
P) or CBA/Ca  (Mls-1  b) mice were obtained from the National 
Cancer Institute (National Institutes of Health, Bethesda, MD) 
and were used as sources of spleen cells for in vivo tolerance experi- 
ments. Homozygous TCR VBS.1, Mls-1  b transgenic mice (6, 16) 
were bred at the University of Pennsylvania. 
Anergy in Thl Clones.  The pigeon cytochrome c (PCC):H-2  k- 
reactive Thl clones, A.E7 and AC24, were maintained by cycles 
of Ag stimulation and rest, as described (17). Anergy was induced 
in rested cells by culture with immobilized anti-CD3 Ab in the 
absence of APC (17), followed  by rest in medium for 3-12 d. Rested 
anergic or control cells (1-2  x  104/well) were then restimulated 
by culture with Ag plus irradiated splenic APC (5  x  105/well) 
in the presence or absence of murine rlL-12 (18; kindly provided 
by Dr. Stanley Wolf, Genetics Institute,  Cambridge, MA). The 
Ag used were PCC (Sigma Chemical Co., St. Louis, MO) or a 
PCC  splice peptide corresponding to  amino acids 86-89; 93- 
103(93E) (19), which was synthesized and HPLC purified in the 
Department of Pathology and Laboratory  Medicine  Protein Facility, 
University of Pennsylvania.  Aliquots of supernatant were removed 
from restimulation cultures on day 2 to assay IFN-3, production, 
and cells were then pulsed with [3H-methyl]TdR  (1/~Ci/well) for 
18 h before harvesting (PHD  Cell Harvester; Cambridge Tech- 
nology, Inc., Watertown, MA). Triplicate  values  for each assay  were 
generally within 15%  of the SEM. 
T Cell Anergy In Viva  Adult TCR Vfl8.1 transgenic  mice were 
injected intravenously with 1.5  x  107 Mls-P-positive T-depleted 
CBA/J spleen cells to induce anergy, or were injected with PBS 
for control mice. On day 14 after injection, the inguinal, popliteal, 
axillary, brachial, and cervical LN were removed and CD4 + T cells 
were purified and restimulated (5  x  104/well) for 84 h with Mls- 
P-positive stimulator cells (5  x  10S/well), as described (6), in the 
presence or absence of routine rlL-12. 
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an ELISA assay that employed the R4-6A2 mAb (20) for capture, 
and a polyclonal rabbit anti-mouse IFN-3, serum for detection with 
horseradish peroxidase-coupled  donkey anti-rabbit IgG (Jackson 
ImmunoResearch Laboratories, Inc., West Grove, PA) and the sub- 
strate, 2,2'-azino-di[3-ethyl-benzthiazoline sufonate(6)] (Kirkegaard 
& Perry Laboratories, Inc., Gaithersburg,  MD). Dilutions  of cul- 
ture supernatants were assayed  in the linear portion of the dose-re- 
sponse curve. OD405 values were converted to units  based on a 
standard IFN-3' preparation obtained from GIBCO BILL (Gaithers- 
burg, MD). 
Results and Discussion 
Induction of IL-12  Responsiveness for  Proliferation.  The 
CD4 §  Thl  clone,  A.E7,  was  cultured  with  APC  and 
suboptimal concentrations of specific Ag, in the presence or 
absence of exogenous murine  rlL-12  (Fig.  1).  A  low level 
of proliferation in response to IL-12 was noted in the absence 
of Ag, but addition of Ag to the culture resulted in greatly 
increased proliferation  to IL-12, even at Ag concentrations 
that alone stimulated little proliferation.  Optimal responses 
were found with IL-12 at 1-3 ng/ml, and were always syner- 
gistic with Ag stimulation. Similar results were found with 
two additional Thl clones (Fig.  2 A  and data not shown). 
Thus, Ag/APC activation can stimulate the Thl clones used 
in this study for a proliferative response to IL-12, as has been 
reported  for other  T  ceUs (11). 
Impaired Induction of lL-12-mediated Proliferation in Anergic 
Tkl  Cells.  As previously reported,  activation of Thl calls 
by immobilized anti-CD3 Ab in the absence of APC results 
in the induction of anergy, which is characterized by the long- 
lived inability to produce IL-2 or to proliferate to subsequent 
stimulation by Ag plus competent APC (17, 21).  Thl cells 
constitutively express IL-2R, and, after induction of anergy, 
rested anergic cells continue to express IL-2R and to main- 
tain proliferative responses to exogenous IL-2 (1-3). In con- 
trast,  the ability to proliferate in response to IL-4 must be 
induced in Thl cells,  and anergic cells are defective for this 
induction by Ag (8). Similar to the IL-4 situation,  optimal 
proliferation  in response to IL-12 must  also be induced in 
Thl cells. Therefore, to determine whether anergic Thl ceils 
can be induced by Ag to proliferate to IL-12,  the A.E7 or 
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Figure  1.  Synergistic  activa- 
tion of Thl cell proliferation by 
Ag and 1L-12. A.E7 cells were cul- 
tured with APC plus Ag (PCC') 
in the absence (closed symbols) or 
presence (open symbols) of murine 
rlL-12 (0.2 ng/ml). Proliferation 
was assessed by incorporation of 
[3HITdR (cpm). 
AC24 Thl  clones were first precultured with immobilized 
anti-CD3 Ab to induce anergy, and then were rested before 
restimuIation  with  Ag/APC in the presence or absence of 
murine  rlL-12. 
As shown in Fig. 2, proliferative anergy to Ag/APC alone 
was evident in cells that had been precultured with immobi- 
lized anti-CD3  Ab (Fig.  2,  open symbols, 0 ng/ml  IL-12). 
Proliferation to IL-12 in the absence of Ag was low for both 
control and anergic cells (Fig. 2, closed  symbols). The striking 
observation was that the Ag-mediated induction of respon- 
siveness to IL-12 was considerably decreased in anergic vs con- 
trol cells  (Fig.  2, open boxes vs open triangles, respectively), 
indicating that anergic cells are severely impaired for induc- 
tion of IL-12 responsiveness. This result was confirmed with 
three Thl clones and was observed at all Ag concentrations 
tested (data not shown). Decreased proliferation to IL-12 was 
apparent both in anergic cells rested for a relatively short time, 
such as 4-5 d (Fig.  2, A  and B) and in those cells rested for 
12 d after induction of anergy (Fig.  2 C). Decreases ranged 
from 50-85% when IL-12 was present at maximal concen- 
trations,  and anergic cells were 10-1,000-fold less sensitive 
to IL-12 than control cells. The minimal IL-12-mediated en- 
hancement of proliferation still evident in anergic cells cul- 
tured with Ag may reflect a small number of cells in the popu- 
lation  that  escape anergy  induction,  or may indicate  that 
anergic cells exhibit a greatly decreased, but not completely 
abolished response to IL-12. These results thus demonstrate 
that, in addition to a block in IL-2 production (1-3, 7) and 
a block in the induction of competency to proliferate to IL-4 
(8), long-term anergic Thl cells are also impaired for the TCR- 
mediated induction of IL-12 responsiveness. All three defects 
result in T cells that are compromised for proliferation, since 
anergic  cells  cannot  produce  IL-2  and  cannot  respond  to 
growth factors secreted by other cell types. 
Role of  lL-2 in the Induction of  IL-12 Responsiveness.  To de- 
termine whether the well-documented defect in IL-2 produc- 
tion in anergic cells contributes to the additional defect in 
IL-12 responsiveness, we first  tested whether ongoing IL-2 
synthesis was required for proliferation to IL-12 after Ag stim- 
ulation. Thus, rested control or anergic A.E7 cells were acti- 
vated overnight with APC and Ag at the concentrations  shown 
in Fig. 3 A, in the absence oflL-12. APC were then removed, 
and washed T cells were cultured with IL-12 in the presence 
or absence of Cyclosporin A  (CsA) to inhibit  any residual 
IL-2 production in control cell samples.  CsA had little effect 
on the IL-12-mediated proliferation of Ag-preactivated con- 
trol or anergic cells,  indicating  that  the anergic cell defect 
cannot be explained by ongoing IL-2 production in control, 
but not  anergic  cells. 
However, a requirement for IL-2 during the Ag activation 
step was still possible. This question was addressed using two 
approaches. First, control A.E7 cells were activated by Ag/APC 
in the presence of CsA to block IL-2 synthesis. T cells were 
then recovered, washed, and cultured with IL-12 alone.  As 
seen in Fig. 3 B, the presence of CsA during the Ag activa- 
tion step did, in fact, partially inhibit the subsequent response 
to IL-12, suggesting that IL-2 production, or another CsA- 
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Figure  2.  Anergic  Thl cells are defective for induction of 
I1112-mediated proliferation. (/1) Control or anergic AC24 
cells were rested for 4 d before restimulation by APC plus 
PCC at 0 or 0.25/xM, in the presence of increasing concen- 
trations of IL-12. (B) Control or anergic  A.E7 cells were rested 
for 5 d before restimulation with APC plus PCC at 0 or 20 
#M, in the presence of IL-12. (C) Control or anergic A.E7 
cells were rested for 12 d before restimulation with APC plus 
PCC at 0 or 25 #M, in the presence of 11112. Control cells 
(triangles);  anergic  cells (boxes). Plus PCC (open symbols);  minus 
PCC (closed symbols). 
sensitive signaling pathway, is required for the induction of 
IL-12 responsiveness.  We therefore  employed a  second ap- 
proach, in which control or anergic A.E7 cells were activated 
by Ag/APC in the presence of exogenous IL-2, to determine 
whether  IL-2 reconstitution  of anergic cell activation  cul- 
tures would allow subsequent proliferation to IL-12 at con- 
trol cell levels. 
Fig. 3 C  demonstrates that the IL-12-mediated prolifera- 
tion of both anergic and control ceils was enhanced by prior 
exposure to IL-2, even in the absence of Ag. It is interesting 
to note that control cell proliferation to IL-12 was also en- 
hanced by exposure to IL-2 during Ag activation, suggesting 
suboptimal Ag-mediated IL-2 production for this response 
by control cells,  and supporting a role for IL-2 during induc- 
tion of IL-12 responsiveness. It is difficult to evaluate the IL-2 
concentration needed during  activation  for optimal  subse- 
quent IL-12-mediated proliferation,  due to IL-2 use during 
the  activation  step.  Complementary experiments  that  em- 
ployed anti-IL-2/IL-2R Ab to block endogenous IL-2 use by 
control cells  were inconclusive because complete inhibition 
was not achieved (data not shown). However, the data shown 
in Fig. 3  C  indicate that IL-2 reconstitution of anergic cell 
Ag activation cultures resulted  in only a marginal increase 
in subsequent proliferation to IL-12, and was insufficient to 
allow IL-12-mediated proliferation at control cell levels. The 
IL-12 response of anergic cells activated with an optimal Ag 
concentration plus IL-2 was only 60% of the response found 
with control cells activated minus IL-2, and was only 20% 
of the  response  of control cells  activated  plus  IL-2.  These 
results indicate that defective ILo2 production by anergic cells 
is not solely responsible for the defect in induction of IL-12 
responsiveness. Similar results were found when the anergic 
cell defect for induction of IL-4 responsiveness  was analyzed (8). 
Impaired Induction of lL-12-mediated Proliferation  Is Observed 
in  Anergic  CD4 +  T  Cells  Tolerized  In  Vivo.  We  tested 
whether  normal T  cells  that  are tolerized in vivo are also 
resistant for the induction of IL-12 responsiveness.  Anergic 
CD4 + T  cells were obtained from TCR VB8.1  transgenic 
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Figure 3.  Effects of CsA and I112 on IL-12- 
mediated proliferation. (A) CsA does not inhibit 
the  IL-12-mediated proliferation of control  or 
anergic Thl cells after activation  by Ag:APC. Con- 
trol (open circles)  or anergic (closed  circles) A.E7 cells 
were rested for 8 d and then were activated  for 18 h 
by culture with APC plus Ag at the concentra- 
tions indicated. Viable cells were then collected, 
washed, and cultured with II,12 (1 ng/ml) in the 
presence (broken lines) or absence (solid lines) of  CsA 
(200 ng/ml) for 2 d. Note that the anergic cells 
required a 100-fold  greater Ag concentration than 
control cells to achieve a comparable subsequent 
response to IL-12. (B) CsA does inhibit the Ag- 
mediated induction of IL-12 responsiveness. Control A.E7 cells were cultured for 18 h without Ag (open symbols) or with 50/~M PCC peptide plus 
APC (solid symbols), in the presence of CsA at 0 ng/ml (circles), 100 ng/ml (boxes), or 500 ng/ml (triangles). Viable cells were then recovered, washed, 
and incubated with 11112 for proliferation (2 x  104/well). Cells precuhured with or without CsA had comparable recoveries and subsequent responses 
to exogenous 1112 (data not shown), demonstrating that CsA was not toxic in the activation step. (C) I112 addition during Ag activation does not 
fully reconstitute the subsequent response of anergic cells to 11112. Control or anergic A.E7 cells were rested for 3 d and then were cultured for 18 
h with APC in the absence or presence of 5 /~M Ag, plus or minus exogenous 11:2 (0.5 ng/ml).  After culture with Ag/I112, viable T cells were 
recovered, washed, and rested for 3 d in medium alone. Finally, viable cells were collected for stimulation of proliferation in response to Ib12 alone 
(1 ng/ml) at 104 cells/well. Cells cultured without 11.-12 incorporated only background levels of [3H]TdK (180-480 cpm; data not shown). Control 
cells (-) 1112 (solid bars); control cell (+) IL-2 (hatched bars); anergic cells (-) IL-2 (open bars); and anergic cells (+) 1I:2 (horizontal st@es). Although 
the growth of anergic cells in exogenous IL-2  can result in the reversal of anergy (17, 24), anergy was not lost in these experiments, perhaps because 
cell division was limited after a single exposure to 1112. Anergic cell recoveries from cultures containing Ib2 were increased by twofold over those 
from cultures without 1112, but we have found that a fivefold  increase is needed to demonstrate reversal of anergy (Quill, H., unpublished observations). 
1067  Quill et al.  Brief  Definitive Report Mls-1  b mice after injection of Mls-l'-positive spleen cells. 
These transgenic mice express V/58.1  on >95%  of periph- 
eral T cells and become tolerant for TCR-mediated prolifer- 
ative responses after intravenous exposure to the Mls-1 a su- 
perantigen that is recognized by V/38.1 (6). The persistence 
of a large number of anergic VBS.1  cells is evident in the 
periphery of these mice, and these anergic cells are unable 
to produce IL-2 or to proliferate when stimulated in vitro 
with Mls-P-positive APC (6, and Table 1). In the presence 
of IL-12, both control and anergic cells  showed enhanced 
proliferation over that seen with Ag alone, but the anergic 
cell response was considerably lower than that found with 
control cells  (Table  1).  Therefore, anergic  CD4 +  T  cells 
tolerized in vivo also exhibit impaired IL-12 responsiveness, 
similar to our findings with Thl clones that are tolerized 
in vitro. 
Effect of lL-12 on the Production  of lFN-?"  by Anergic  Thl 
Cells.  In addition to stimulating T cell proliferation, IL-12 
is known to induce IFN-3, production by T cells and to syn- 
ergize with TCR-mediated stimulation, IL-2 and other stimuli 
for IFN-3' production (12, 13). As an independent assay for 
induction of IL-12 responsiveness in anergic Thl clones, we 
also measured IFN-3, secretion during culture with Ag/APC 
plus IL-12. In contrast to the nearly complete block in in- 
duction of proliferation to Ag/APC,  anergic Thl cells can 
be stimulated to produce [FN-3', but they are less sensitive 
to Ag for this response (2). As shown in Fig.  4 B, anergic 
AC24 cells stimulated by Ag/APC, in the absence of IL-12, 
required a 100-fold higher Ag concentration than control cells 
for equivalent IFN-3' production. In the absence of Ag, IL-12 
did not stimulate IFN-3, secretion in either control or anergic 
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Figure  4.  IL-12-mediated  enhancement of IFN-3, production  by Ag- 
activated  anergic  vs control  Thl cells. Control (circles,  solid lines) or anergic 
(boxes, broken lines) AC24 cells were rested for 13 d before  restimulation 
with Ag/APC in the absence (closed symbols) or presence (open symbols) 
of rlL-12 (5 ng/ml). Aliquots of culture supernatants were removed  for 
IFN-y assay (B) and the cells were then pulsed with pH]TdR to assess 
proliferative  responses (A). Similar  results were found  with anergic  A.E7 
cells, although  A.E7 clone  was generally  less sensitive  than the AC24 clone 
for IL-12-mediated  enhancement of ]FN-3, production. 
cells. When IL-12 was added with Ag, the response of both 
control and anergic cells was enhanced, such that a 100-fold 
lower Ag concentration could be used to stimulate IFN-3' 
production. However, even in the presence of supraoptimal 
IL-12 concentrations, IFN-3/production by anergic cells was 
less than that found for control cells. Addition of exogenous 
IL-2 together with IL-12 during Ag stimulation (data not 
shown) could not fully restore the IFN-3, response, confirming 
the results obtained in proliferation assays and indicating that 
Table  1.  Impaired Induction of IL-I2-mediated Proliferation in Anergic CD4 + T  Cells Tolerized to Mls-l" In  Vivo 
Stimulator  cells* 
CBA/Ca  CBA/J 
T  cell source*  IL-12 (3 ng/ml)  (Mls-1  b)  (Mls-1  a) 
Experiment  1 
Control mice 
Mls-l'-inoculated mice 
Experiment  2 
Control mice 
Mls-la-inoculated  mice 
cpm 
-  325 (109)s  48,316 (2,741) 
+  374 (80)  84,207 (4,119) 
-  270 (96)  736 (110) 
+  637 (200)  3,731 (869) 
-  210 (17)  20,908 (1,245) 
+  294 (85)  36,109 (1,798) 
-  439 (132)  1,970 (270) 
+  364 (66)  3,945 (1,476) 
* CD4 § LN T cells were isolated from Mls-1  b, V•8.1  transgenic mice inoculated with Mls-1  ~ spleen cells 14 d previously, or were isolated from 
control V/38.1 mice injected only with PBS. 
T-depleted spleen cells from Mls-1  b or Mls-1  a normal mice were irradiated and cultured with V~8.1 T cells to assess T cell proliferative  responses. 
S  SEM of triplicate samples, 
1068  Defective  IL-12 Response in Anergic T Cells impaired induction of IL-12 responsiveness cannot be explained 
solely by the failure of anergic cells to produce IL-2. 
Although the clear  functional consequence of anergy is 
decreased Ag-dependent IFN-y production even in the pres- 
ence of IL-12, it is not yet known why IL-12 cannot rescue 
the IFN-3, response.  Our data suggest the possibility that 
a primary IL-12-independent defect in Ag-mediated IFN-'y 
production may explain the decrease in total IFN-y secretion 
by anergic cells cultured with Ag plus IL-12. As seen in Fig. 
4 B, Ag does activate  IL-12-dependent IFN-3,  secretion in 
anergic cells, but only to a suboptimal level vs control cells. 
The difference between control and anergic cells seen in the 
absence of IL-12 is maintained in the presence of IL-12. Thus, 
although IL-12 cannot override the anergic cell defect in IFN-  7 
production, the relative activity of IL-12 is similar with con- 
trol and anergic cells, suggesting that the limited IFN-7 re- 
sponse induced by Ag can be enhanced normally by IL-12 
in anergic cells. It is possible,  therefore, that decreased syn- 
ergy between IL-12 and Ag/APC-mediated signals reflects 
an impaired contribution by TCR-mediated events, and not 
an intrinsic defect in the induction of the response to IL-12. 
Although other explanations are possible, this interpretation 
would suggest a dissociation of IL-12 responses  in anergic 
cells, such that IL-12-mediated proliferation is severely  blocked, 
but that the IL-12-mediated enhancement of IFN-3' produc- 
tion can still occur.  Dissociation of IL-12 responses  might 
reflect different signaling pathways used for proliferation vs 
IFN-y production, or might result from heterogeneity in the 
IL-12R, which has not yet been well characterized (22). 
IL-12 is thought to play a major role in generating and, 
perhaps, in perpetuating Thl-type responses in vivo (23), and 
it is of interest that anergy in both Thl clones and in normal 
CD4 § T cells includes tolerance for IL-12-mediated prolifer- 
ation. Once reagents specific for the murine IL-12R are avail- 
able, it will be important to determine if the defect in anergic 
cells reflects an inability to express one or more of the puta- 
tive subunits of the IL-12R (22),  or alternatively, reflects a 
block in signaling pathways mediated by this receptor.  The 
current results extend our understanding of anergic CD4 + 
T cells by demonstrating an additional functional defect that 
may contribute to the maintenance of tolerance for Thl-type 
responses. 
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